Traditional clinical trials have three main steps: design the trial, conduct the trial, and analyze the data using a pre-specified analysis plan. A 2018 paper by Pullman, et al in BMC Medicine raises issues with this process and proposes “adaptive designs” (AD’s). As...
Adaptive Clinical Trials
Category
UC Irvine Initiates Participation in Worldwide NIAID-Sponsored Adaptive COVID-19 Clinical Trial Assessing Remdesivir (Gilead)
University of California, Irvine (UCI) joins other pathbreaking major academic centers serving as clinical investigative sites nationwide to test Gilead’s remdesivir, the novel antiviral drug developed as a treatment for the Ebola and Marburg virus. With UCI’s...
Precision Promise–PanCAN’s Adaptive Platform Clinical Trial—Opens at 14 Clinical Trial Consortium Sites Across USA in F2019
The Pancreatic Cancer Action Network (PanCAN) offers an adaptive platform for clinical research, known as Precision Promise, plans on launching a clinical trial at 14 Clinical Trial Consortium sites across American starting in the Fall of 2019 through early 2020. An...